Publication | Closed Access
Shunt Bilirubin: Evidence for Two Components
66
Citations
9
References
1963
Year
HypertensionBiochemistryCardiovascular DiseaseHeme HomeostasisHeme PrecursorsBioanalysisHematologyPhysiologyHeme DegradationLaboratory MedicineBone MarrowDelta-aminolevulinic AcidAntihypertensive TherapyClinical ChemistryMetabolismMedicineShunt BilirubinHealth Sciences
Studies with C(14)-labeled glycine and delta-aminolevulinic acid as heme-bilirubin precursors in man indicate that the early labeled or shunt bilirubin consists of two fractions. Fraction 1 requires 1 to 24 hours for maximum synthesis, is not dependent on marrow erythropoietic heme synthesis, and is possibly of anabolic origin (formed by a direct pathway from heme precursors). Fraction 2 requires 3 to 4 days for maximum production, is dependent on heme synthesis, and probably has its origin in the bone marrow, as a degradation product of red-cell heme.
| Year | Citations | |
|---|---|---|
Page 1
Page 1